<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya disease</z:e> is a cerebrovascular disease characterized radiologically by progressive narrowing and occlusion of the arteries contributing to the circle of Willis and its branches </plain></SENT>
<SENT sid="1" pm="."><plain>There is formation of an exuberant collateral network of blood vessels at the base of the brain, which is thought to arise in response to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Clinically, the course is variable, with patients having repeated <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo>, <z:hpo ids='HP_0001297'>strokes</z:hpo>, <z:hpo ids='HP_0002076'>migraine</z:hpo>, and <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Effective treatment is not available </plain></SENT>
<SENT sid="4" pm="."><plain>The etiology and pathophysiology of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> are largely unknown </plain></SENT>
<SENT sid="5" pm="."><plain>Two patients with arteriographically proven <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> were identified </plain></SENT>
<SENT sid="6" pm="."><plain>Both patients were symptomatic before age 5 years </plain></SENT>
<SENT sid="7" pm="."><plain>Despite successful encephaloduroarteriosynangiosis revascularization procedures, they continued to experience an inexorable downhill course </plain></SENT>
<SENT sid="8" pm="."><plain>A <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi> (nicardipine HCl) was introduced in order to prevent further symptoms </plain></SENT>
<SENT sid="9" pm="."><plain>After the introduction of nicardipine, no further <z:hpo ids='HP_0001297'>strokes</z:hpo> occurred in either patient </plain></SENT>
<SENT sid="10" pm="."><plain>There were no further episodes of <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo>, <z:hpo ids='HP_0001250'>seizures</z:hpo>, or <z:hpo ids='HP_0002315'>headache</z:hpo> in one patient and decreased frequency in the other </plain></SENT>
<SENT sid="11" pm="."><plain>In patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e>, nicardipine may have a beneficial effect on cerebral hemodynamics and may prevent ischemic sequelae by optimizing existing collateral circulation </plain></SENT>
</text></document>